1. Prognostic Value of Plasma HER2 Gene Copy Number in HER2-Positive Metastatic Breast Cancer Treated with First-Line Trastuzumab


    Ran Ran et al, 2020, OncoTargets and Therapy CrossRef
  2. Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study
    Sander Ellegård et al, 2022, Frontiers in Oncology CrossRef
  3. Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers
    Christopher Y.C. Chow et al, 2022, Frontiers in Oncology CrossRef